2023
Effect of a Personalized Tobacco Treatment Intervention on Smoking Abstinence in Individuals Eligible for Lung Cancer Screening
Cartmel B, Fucito L, Bold K, Neveu S, Li F, Rojewski A, Gueorguieva R, O'Malley S, Herbst R, Toll B. Effect of a Personalized Tobacco Treatment Intervention on Smoking Abstinence in Individuals Eligible for Lung Cancer Screening. Journal Of Thoracic Oncology 2023, 19: 643-649. PMID: 37977486, PMCID: PMC10999350, DOI: 10.1016/j.jtho.2023.11.012.Peer-Reviewed Original ResearchStandard of careLung cancer screeningCancer screeningQuit ratesGain-framed messagingPack-year smoking historySmoking cessation ratesSmoking quit ratesNumber of cigarettesTobacco treatment interventionsYears of ageCessation/reductionChi-square testSelf-reported numberSmoking historyStandard careCessation ratesRandomized trialsTobacco treatmentTobacco cessationBiomarker feedbackLung cancerSmoking abstinencePost randomizationSmoking behavior
2021
Preoperative contingency management intervention for smoking abstinence in cancer patients: trial protocol for a multisite randomised controlled trial
Rojewski AM, Fucito LM, Baker NL, Palmer AM, Foster MG, Warren GW, Bernstein SL, Toll BA. Preoperative contingency management intervention for smoking abstinence in cancer patients: trial protocol for a multisite randomised controlled trial. BMJ Open 2021, 11: e051226. PMID: 34187835, PMCID: PMC8245459, DOI: 10.1136/bmjopen-2021-051226.Peer-Reviewed Original ResearchConceptsSmoking abstinenceSelf-reported smoking abstinenceCancer-specific mortalityNicotine replacement therapyTime of surgeryDay of surgerySmoking cessation treatmentCancer treatment toxicitiesSouth Carolina Institutional Review BoardEffect of CMBreath carbon monoxideContingency management interventionCO breath testInstitutional review boardSubstantial health risksOperable cancerContinued smokingPeer-reviewed journalsPreoperative periodStandard careSurgical complicationsTreatment toxicitySecondary malignanciesCessation treatmentReplacement therapy
2020
A Preoperative Contingency Management Intervention for Smoking Abstinence in Cancer Patients: A Preliminary Randomized Controlled Trial
Rojewski AM, Fucito LM, Baker NL, Krishnan-Sarin S, Carpenter MJ, Bernstein SL, Toll BA. A Preoperative Contingency Management Intervention for Smoking Abstinence in Cancer Patients: A Preliminary Randomized Controlled Trial. Nicotine & Tobacco Research 2020, 23: 1064-1067. PMID: 33340400, PMCID: PMC8248947, DOI: 10.1093/ntr/ntaa266.Peer-Reviewed Original ResearchConceptsDay of surgeryCancer surgeryAbstinence ratesContingency management interventionCM patientsCM interventionSeven-day point prevalence abstinence ratesCM groupSelf-reported smoking abstinencePoint prevalence abstinence ratesTobacco treatment programEnd of treatmentIncentives contingentMonetary incentives contingentBreath carbon monoxideCO breath testMultisite pilot studyOperable cancerStandard careNicotine patchCancer patientsSmoking abstinenceSurgical proceduresBreath testPatients
2019
Longitudinal Findings from a Randomized Clinical Trial of Varenicline for Alcohol Use Disorder with Comorbid Cigarette Smoking
Bold KW, Zweben A, Fucito LM, Piepmeier ME, Muvvala S, Wu R, Gueorguieva R, O'Malley SS. Longitudinal Findings from a Randomized Clinical Trial of Varenicline for Alcohol Use Disorder with Comorbid Cigarette Smoking. Alcohol Clinical And Experimental Research 2019, 43: 937-944. PMID: 30817018, PMCID: PMC7039307, DOI: 10.1111/acer.13994.Peer-Reviewed Original ResearchConceptsEnd of treatmentAlcohol use disorderHeavy drinking daysMedical managementCigarette smokingComorbid cigarette smokingUse disordersDrinking daysCo-occurring alcohol use disorderHigh ratePlacebo-controlled trialBetter clinical outcomesAssessment of alcoholPercent of participantsVarenicline treatmentClinical outcomesSmoking abstinenceParallel groupClinical trialsTimeline FollowVareniclineSmoking behaviorAlcohol treatmentPosttreatment outcomesMultisite trial
2018
Effect of Varenicline Combined With Medical Management on Alcohol Use Disorder With Comorbid Cigarette Smoking: A Randomized Clinical Trial
O’Malley S, Zweben A, Fucito LM, Wu R, Piepmeier ME, Ockert DM, Bold KW, Petrakis I, Muvvala S, Jatlow P, Gueorguieva R. Effect of Varenicline Combined With Medical Management on Alcohol Use Disorder With Comorbid Cigarette Smoking: A Randomized Clinical Trial. JAMA Psychiatry 2018, 75: 129-138. PMID: 29261824, PMCID: PMC5838706, DOI: 10.1001/jamapsychiatry.2017.3544.Peer-Reviewed Original ResearchConceptsAlcohol use disorderMedical managementUse disordersCigarette smokingWeek 9Varenicline tartrateEfficacy of vareniclinePlacebo-controlled trialBehavioral health risksComorbid cigarette smokingRace/ethnicityAlcohol dependence criteriaSmoking 2Medication adherenceOutpatient clinicPlacebo pillsMean ageEligible participantsSmoking abstinenceClinical trialsParallel groupPlaceboMAIN OUTCOMEVareniclineWeek 13
2016
Nicotine Replacement Therapy Use Predicts Smoking and Drinking Outcomes among Heavy-Drinking Smokers Calling a Tobacco Quitline
Rojewski AM, Fucito LM, Baldassarri S, Hyland A, Cummings KM, Toll BA. Nicotine Replacement Therapy Use Predicts Smoking and Drinking Outcomes among Heavy-Drinking Smokers Calling a Tobacco Quitline. The Journal Of Smoking Cessation 2016, 12: 99-104. PMID: 35082926, PMCID: PMC8788683, DOI: 10.1017/jsc.2016.12.Peer-Reviewed Original ResearchNicotine replacement therapyHeavy drinking daysDrinking daysNRT useFree nicotine replacement therapyNicotine replacement therapy useHeavy drinking smokersState Smokers' QuitlineTobacco counsellingTherapy useCessation assistanceSmoking statusReplacement therapyTobacco quitlineSmoking abstinenceHazardous drinkersSmokersQuitlineHeavy drinkingSuboptimal useDrinking outcomesAbstinenceDaysCounsellingSignificant barriers
2013
Integrating a Behavioural Sleep Intervention into Smoking Cessation Treatment for Smokers with Insomnia: A Randomised Pilot Study
Fucito LM, Redeker NS, Ball SA, Toll BA, Ikomi JT, Carroll KM. Integrating a Behavioural Sleep Intervention into Smoking Cessation Treatment for Smokers with Insomnia: A Randomised Pilot Study. The Journal Of Smoking Cessation 2013, 9: 31-38. PMID: 24995044, PMCID: PMC4076952, DOI: 10.1017/jsc.2013.19.Peer-Reviewed Original ResearchSleep interventionsCessation outcomesSmoking abstinenceBehavioral sleep interventionsCognitive behavioral therapyCessation treatmentQuit dateSmoking cessation outcomesSmoking cessation treatmentCessation counsellingCessation failurePoint prevalence abstinence ratesBehavioral interventionsSmoking cessation counsellingInsomnia symptomsSleep changesNicotine patch therapySleep disturbancesSleep efficiencyPilot studyEnd of treatmentLarge sampleAbstinence ratesInsomniaMost participants
2010
Nicotine dependence as a moderator of a quitline-based message framing intervention
Fucito LM, Latimer AE, Carlin-Menter S, Salovey P, Cummings KM, Makuch RW, Toll BA. Nicotine dependence as a moderator of a quitline-based message framing intervention. Drug And Alcohol Dependence 2010, 114: 229-232. PMID: 21036492, PMCID: PMC3044773, DOI: 10.1016/j.drugalcdep.2010.09.012.Peer-Reviewed Original ResearchConceptsMessage framing interventionsNicotine dependence scoresGain-framed messagesNicotine dependenceDependence scoresMore cigarettesPoint prevalence smoking abstinenceNew York State Smokers' QuitlineSmoking cessation treatmentHigh nicotine dependenceState Smokers' QuitlineBaseline total scoreHigher nicotine dependence scoresNicotine dependence levelHigher dependence scoresNicotine medicationsNicotine patchCessation treatmentDependent smokersSmoking abstinenceSmokersSmoking outcomesTotal scoreFraming interventionQuitline